GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q BioMed Inc (OTCPK:QBIO) » Definitions » FCF Yield %

Q BioMed (Q BioMed) FCF Yield % : 0.00 (As of May. 28, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Q BioMed FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Q BioMed's Trailing 12-Month Free Cash Flow is $2.18 Mil, and Market Cap is $0.02 Mil. Therefore, Q BioMed's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Q BioMed's FCF Yield % or its related term are showing as below:


QBIO's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -14.415
* Ranked among companies with meaningful FCF Yield % only.

Q BioMed's FCF Margin % for the quarter that ended in Feb. 2023 was 0.00%.


Q BioMed FCF Yield % Historical Data

The historical data trend for Q BioMed's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q BioMed FCF Yield % Chart

Q BioMed Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -24.94 -13.02 -23.79 -33.21 143.86

Q BioMed Quarterly Data
May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.58 -10.29 -57.47 790.96 -34.58

Competitive Comparison of Q BioMed's FCF Yield %

For the Biotechnology subindustry, Q BioMed's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q BioMed's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q BioMed's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Q BioMed's FCF Yield % falls into.



Q BioMed FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Q BioMed's FCF Yield % for the fiscal year that ended in Nov. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=1.941 / 1.349248
=143.86%

Q BioMed's annualized FCF Yield % for the quarter that ended in Feb. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.138 * 4 / 1.596324
=-34.58%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Q BioMed FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Q BioMed FCF Yield % Related Terms

Thank you for viewing the detailed overview of Q BioMed's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Q BioMed (Q BioMed) Business Description

Traded in Other Exchanges
N/A
Address
C/o Ortoli Rosenstadt LLP, 366 Madison Avenue, 3rd Floor, New York, NY, USA, 10017
Q BioMed Inc is a biomedical acceleration and development company. It has a focus on licensing, acquiring, and providing strategic resources to life sciences and healthcare companies. The company intends to mitigate risk by acquiring multiple assets over time and across a broad spectrum of healthcare-related products, companies, and sectors. Generic Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. It also has three development-stage products: QBM-001 for rare pediatric non-verbal autism spectrum disorder, Uttroside-B for liver cancer, and MAN 01 for glaucoma.
Executives
William S Rosenstadt director, 10 percent owner, officer: Chief Legal Officer ORTOLI ROSENSTADT LLP, 501 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10022
Denis Corin director, 10 percent owner, officer: Chief Executive Officer 10 MARKET STREET, SUITE 427, GRAND CAYMAN E9 KY1-9006
Rick Panicucci director 501 MADISON STREET, 14TH FLOOR, NEW YORK NY 10022
Alan P Lindsay 10 percent owner 580 HORNBY STREET, FIFTH FLOOR, VANCOUVER BC CANADA V6C 2E7 A1